Literature DB >> 10573387

Effect of Saccharomyces boulardii on cAMP- and Ca2+ -dependent Cl- secretion in T84 cells.

D Czerucka1, P Rampal.   

Abstract

Several reports have confirmed that the cooperative interaction between cAMP- and Ca2+-mediated transduction pathways may contribute to the stimulatory or inhibitory regulation of Cl- secretion in intestinal epithelium. Saccharomyces boulardii has been shown to inhibit cholera toxin-induced secretion in rat jejunum. We have identified a 120-kDa protein in medium conditioned by Saccharomyces boulardii that reduces cholera toxin-induced cAMP in intestinal cells. The present study evaluated the effect of medium conditioned by Saccharomyces boulardii on cAMP- and Ca2+-mediated Cl- secretion in T84 cells. Experiments performed with cAMP agonists revealed that 1 hr of preincubation of cells with medium conditioned by Saccharomyces boulardii was necessary to elicit a 40-50% reduction in receptor (cholera toxin, prostaglandin E2, and vasoactive intestinal polypeptide) and nonreceptor (forskolin) mediated cAMP synthesis and 125I efflux. Secretion induced by carbachol was inhibited when cells were pretreated for 1 hr with medium conditioned by Saccharomyces boulardii despite the absence of inhibition of Ins (1,4,5)P3. From this study we conclude that Saccharomyces boulardii exerts an inhibitory effect in vitro on Cl- secretion mediated through both cAMP- and Ca2+-mediated signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573387     DOI: 10.1023/a:1026689628136

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

Review 1.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

2.  Involvement of 5-hydroxytryptamine, prostaglandin E2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo.

Authors:  E Beubler; G Kollar; A Saria; K Bukhave; J Rask-Madsen
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

3.  Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum.

Authors:  I Castagliuolo; J T LaMont; S T Nikulasson; C Pothoulakis
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

4.  A biologic function for an "orphan" messenger: D-myo-inositol 3,4,5,6-tetrakisphosphate selectively blocks epithelial calcium-activated chloride channels.

Authors:  I I Ismailov; C M Fuller; B K Berdiev; V G Shlyonsky; D J Benos; K E Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

5.  Multiple G-protein-dependent pathways mediate the antisecretory effects of somatostatin and clonidine in the HT29-19A colonic cell line.

Authors:  G Warhurst; L A Turnberg; N B Higgs; A Tonge; J Grundy; K E Fogg
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

6.  A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.

Authors:  L V McFarland; C M Surawicz; R N Greenberg; R Fekety; G W Elmer; K A Moyer; S A Melcher; K E Bowen; J L Cox; Z Noorani
Journal:  JAMA       Date:  1994 Jun 22-29       Impact factor: 56.272

7.  Protein kinase C activity does not mediate the inhibitory effect of carbachol on chloride secretion by T84 cells.

Authors:  A E Traynor-Kaplan; T Buranawuti; M Vajanaphanich; K E Barrett
Journal:  Am J Physiol       Date:  1994-11

8.  Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants.

Authors:  J P Buts; G Corthier; M Delmee
Journal:  J Pediatr Gastroenterol Nutr       Date:  1993-05       Impact factor: 2.839

9.  [Influence of Saccharomyces boulardii on jejunal secretion in rats induced by cholera toxin].

Authors:  N Vidon; B Huchet; J C Rambaud
Journal:  Gastroenterol Clin Biol       Date:  1986-01

10.  Targeting of cholera toxin and Escherichia coli heat labile toxin in polarized epithelia: role of COOH-terminal KDEL.

Authors:  W I Lencer; C Constable; S Moe; M G Jobling; H M Webb; S Ruston; J L Madara; T R Hirst; R K Holmes
Journal:  J Cell Biol       Date:  1995-11       Impact factor: 10.539

View more
  13 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

Review 2.  Probiotics in clostridium difficile Infection.

Authors:  Xi Na; Ciaran Kelly
Journal:  J Clin Gastroenterol       Date:  2011-11       Impact factor: 3.062

3.  Studies on the time course of the effects of the probiotic yeast Saccharomyces boulardii on electrolyte transport in pig jejunum.

Authors:  B Schroeder; C Winckler; K Failing; G Breves
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

4.  Dose-response relationship and mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhea in rats.

Authors:  Philippe Girard; Yannick Pansart; Ingrid Lorette; Jean-Marie Gillardin
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

5.  The effect of Saccharomyces boulardii on human colon cells and inflammation in rats with trinitrobenzene sulfonic acid-induced colitis.

Authors:  Sang Kil Lee; Youn Wha Kim; Sung-Gil Chi; Yeong-Shil Joo; Hyo Jong Kim
Journal:  Dig Dis Sci       Date:  2008-07-10       Impact factor: 3.199

6.  Saccharomyces boulardii and bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera.

Authors:  Johnathan Sheele; Jessica Cartowski; Angela Dart; Arjun Poddar; Shikha Gupta; Eric Stashko; Bhaskara S Ravi; Crawford Nelson; Ajay Gupta
Journal:  Pathog Glob Health       Date:  2015-08-11       Impact factor: 2.894

7.  The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea.

Authors:  Atakan Sezer; Ufuk Usta; Irfan Cicin
Journal:  Med Oncol       Date:  2008-12-09       Impact factor: 3.064

8.  Saccharomyces boulardii inhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferation.

Authors:  S Thomas; I Przesdzing; D Metzke; J Schmitz; A Radbruch; D C Baumgart
Journal:  Clin Exp Immunol       Date:  2009-01-21       Impact factor: 4.330

9.  Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation.

Authors:  Anna Murzyn; Anna Krasowska; Piotr Stefanowicz; Dorota Dziadkowiec; Marcin Łukaszewicz
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

Review 10.  Beneficial effects of probiotic and food borne yeasts on human health.

Authors:  Saloomeh Moslehi-Jenabian; Line Lindegaard Pedersen; Lene Jespersen
Journal:  Nutrients       Date:  2010-04-01       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.